Sesen bio, inc. (SESN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash Flows from Operating Activities:
Cash Flows from Operating Activities:
Net income (loss)

-59,456

-107,500

-80,704

-81,587

-36,210

-33,693

-33,483

-28,573

-26,931

-29,029

-26,013

2,579

3,404

1,891

-4,907

-34,087

-34,502

-33,452

-31,262

-32,243

-33,458

-34,156

0

0

0

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation

201

219

216

214

208

208

220

212

252

285

288

259

206

178

185

267

324

366

391

393

405

410

0

0

0

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

26

67

108

132

108

75

44

30

36

0

0

0

Share-based compensation

1,318

1,237

1,259

1,279

1,208

1,283

1,497

1,501

1,538

1,381

1,481

3,372

3,671

4,013

3,985

2,470

2,451

2,529

2,382

2,561

2,460

2,432

0

0

0

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-2

-

-77

-13

2

-110

44

-83

-1,915

-3,104

-3,013

-2,950

-1,131

123

0

0

0

Change in fair value of contingent consideration

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Gain on sale of equipment

-

-

-

-

-

5

19

34

37

108

104

103

100

24

0

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

-735

5,188

165

1,974

2,589

913

720

62

-55

-164

-453

-726

-835

-800

-483

-580

-103

-110

312

-58

350

259

0

0

0

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

25

80

0

0

0

0

-

-

-

-

Accounts payable

385

535

1,192

866

290

460

25

65

179

-760

-395

-1,773

-1,537

-742

-1,681

-25

-455

-1,212

-850

-1,263

-1,279

1,021

0

0

0

Accrued expenses and other liabilities

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-425

-1,250

0

-203

19

779

-451

-59

-100

-195

-304

-1,095

-964

0

0

0

Due to related party

-

-

-

-

-

-

-

-

-

-114

-689

-694

-697

-698

0

0

0

-

-

-

-

-

-

-

-

Net Cash Used in Operating Activities

-38,329

-37,521

-31,318

-29,564

-26,409

-22,800

-18,842

-18,074

-16,988

-17,800

-19,740

6,392

5,893

2,538

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-33,331

-32,751

-29,307

0

0

0

Cash Flows from Investing Activities:
(Purchases) sales of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Cash Flows from Investing Activities:
(Purchases) sales of equipment

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

(Purchases) sales of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net Cash Used in Investing Activities

-136

-136

-144

-50

-7

-2

19

34

27

98

126

530

537

461

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-291

-119

-137

0

0

0

Cash Flows from Financing Activities:
Cash Flows from Financing Activities:
Proceeds from issuance of common stock under ATM Offering, net of issuance costs

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on equipment financing and notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

14,124

15,001

15,001

15,001

877

3,384

3,800

4,217

4,633

0

0

0

Proceeds from issuance of common stock under ATM Offering, net of issuance costs

-

-

-

-

-

-

-

58,226

9,376

0

0

0

0

-

-

-

-

12,650

31,407

30,904

18,684

70,237

0

0

0

Proceeds from exercises of stock options

-

-

-

-

-

-

-

-

-

40

105

221

295

269

205

95

31

63

85

98

105

74

0

0

0

Proceeds from sales of common stock under 2014 ESPP

2

8

7

17

17

20

21

17

17

12

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

42,085

24,455

75,561

0

0

0

Net Cash Provided by Financing Activities

38,529

35,356

31,516

31,613

49,204

58,583

65,316

65,225

16,346

7,005

152

261

335

-13,820

0

0

0

-

-

-

-

-

-

-

-

Net Decrease in Cash, Cash Equivalents and Restricted Cash

26

-2,301

9

1,970

22,759

35,752

46,528

47,220

-580

-10,662

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-15,646

-45,010

-32,130

-17,980

10,419

8,463

-8,415

46,117

0

0

0

Supplemental disclosure of non-cash operating activities:
Right-of-use assets related to the adoption of ASC 842

0

236

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for amounts included in the measurement of lease liabilities

153

153

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of non-cash financing activities:
Conversion of Series A and Series B preferred stock into 8,260,444 shares of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

56,678

0

0

0

Conversion of preferred stock warrants into common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

247

0

0

0

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

949

1,219

1,418

930

802

586

446

335

0

0

0